The document provides information on the medication Zetia (ezetimibe), including its classification as a cholesterol lowering agent, dosage of 10mg taken orally daily, mechanism of action in inhibiting intestinal cholesterol absorption, and nursing implications such as monitoring for potential interactions and side effects like increased liver enzymes or muscle pain. The nursing process section addresses assessing the patient's diet and muscle symptoms, reasons for holding the medication like rhabdomyolysis or liver disease, and evaluating the effectiveness by checking cholesterol levels.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as XLS, PDF, TXT or read online from Scribd
The document provides information on the medication Zetia (ezetimibe), including its classification as a cholesterol lowering agent, dosage of 10mg taken orally daily, mechanism of action in inhibiting intestinal cholesterol absorption, and nursing implications such as monitoring for potential interactions and side effects like increased liver enzymes or muscle pain. The nursing process section addresses assessing the patient's diet and muscle symptoms, reasons for holding the medication like rhabdomyolysis or liver disease, and evaluating the effectiveness by checking cholesterol levels.
The document provides information on the medication Zetia (ezetimibe), including its classification as a cholesterol lowering agent, dosage of 10mg taken orally daily, mechanism of action in inhibiting intestinal cholesterol absorption, and nursing implications such as monitoring for potential interactions and side effects like increased liver enzymes or muscle pain. The nursing process section addresses assessing the patient's diet and muscle symptoms, reasons for holding the medication like rhabdomyolysis or liver disease, and evaluating the effectiveness by checking cholesterol levels.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as XLS, PDF, TXT or read online from Scribd
The document provides information on the medication Zetia (ezetimibe), including its classification as a cholesterol lowering agent, dosage of 10mg taken orally daily, mechanism of action in inhibiting intestinal cholesterol absorption, and nursing implications such as monitoring for potential interactions and side effects like increased liver enzymes or muscle pain. The nursing process section addresses assessing the patient's diet and muscle symptoms, reasons for holding the medication like rhabdomyolysis or liver disease, and evaluating the effectiveness by checking cholesterol levels.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as XLS, PDF, TXT or read online from Scribd
Download as xls, pdf, or txt
You are on page 1of 1
INDEX NURS 2236 Clinical Form 3: Clinical Medications Worksheet
(You will need to made additional copies of these forms)
Generic Trade Classification Dose Route Time/Frequency Name Name ezetimibe Zetia Cholesterol 10 mg PO qday hs Lowering agent Peak Onset Duration Normal Dosage range 10mg qday PO 4-12 hr UNK UNK
Why is your patient taking this medication? For IV meds, compatability with IV drips and/or solutions
Mechanism of action and indications Nursing Implications (what to focus on)
Treatment of primary hypercholesterolemia alone or with Contraindications/warnings/interactions Hypersensitivity; concurrent us with an HMG-CoA reductace inhibitor (statin); treatment of HMG-CoA reductase inhibitor in patients with active liver disease or elevated serum homozygous sitosterolemia as an adjunct to diet transaminases; moderate to severe hepatic disease; concurrent administration with fibrates; lactation; pregnancy; mild hepatic insufficiency. Works at the lining of the small intestine inhibiting the absorption of cholesterol, but does not inhibit cholesterol Common side effects Fatigue; arthralgia; back pain; myalgia; angiedema; synthesis in the liver or increases biles acid excretion. myopathy; dizziness; headache; abdominal pain; diarrhea; pharyngitis; sinusitis; Thus it decreases the amount of intestinal cholesterol cough; thrombocytopenia; rash; hepatitis; pancreatitis; rhabdomyolysis. available to the liver. Lowers both total cholesterol and nausea; low-density lipd (LDL) cholesterol. Interactions with other patient drugs, OTC, or herbal Lab value alterations caused by medicine medicines (ask patient specifically) Evaluate serum cholesterol and triglyceride levels before initiating, after 2-4 week cholestryramine; bile acid sequestrants; fibrates; of therapy, and periodically thereafter. May cause increased liver transaminases; cyclosporine; HMG CoA-reductase inhibitors Monitor liver enzymes. Be sure to teach the patient the following about this medication Medication should be used in conjunction with diet restrictions. Exercise and cessation of smoking. Does not assist in weight loss; Notify doctor of unexplained muscle pain, tenderness, or weakness occur. Follow-up appointments are important to determine effectiveness and to monitor for side effects
Nursing Process - Assessment Assessment Evaluation
(Pre-administration assessment Why would you hold or not give Check after giving Obtain diet history; this med? Assess for unexplained muscle pain, tenderness Decrease in serum LDL and total cholesterol and weakness. Rhabdomyolysis levels. Angioedema Increase in HDL cholesterol levels Liver disease